aroma

Aromatase Inhibitors drug Femara after Tamoxifen therapy protects from breast cancer recurrence

Aromatase Inhibitors drug, Femara given after 5 years of Tamoxifen therapy is found to give protection against occurrence of Breast cancer recurrence. Breast cancer is the second leading cause of cancer// in women. Breast cancer mostly occurs in post menopausal women and various risk factors are attributed for the occurrence of breast cancer. Treatment of breast cancer initially involve...

Aromatherapy: Ambient odors of orange and lavender reduce anxiety

Odors have long been known to be capable of altering the emotional state of humans. Physiological and psychological effects of essential oils have been acknowledged in folk medicine and aromatherapy for a long time//. Citrus and lavender fragrances have been particularly attributed with mood enhancing properties by aromatherapists. Recently a study, published in the September issue of th...

Grapefruit Aroma Makes Women Appear Younger

A study conducted by the Smell and Taste Institute in Chicago has revealed that the scent of grapefruit can make a woman appear younger to men. // It is the aroma of the fruit that has this effect. Other aromas like lavender, banana, peppermint or broccoli do not have such effects, according to the study....

Aromatase Inhibitors Better Than Tamoxifen For Treating Receptor-Positive Early Breast Cancer

Researchers have found that aromatase inhibitors like anastrozole are more effective in treating postmenopausal women with hormone receptor-positive early breast cancer// than tamoxifen according to study published in the "The Lancet Oncology" journal. Researchers followed more than 6,000 postmenopausal women with early breast cancer for more than 5 years and found that patients on ana...

Benefits Of Aromatherapy

Aromatherapy, the treatment using scents, is one of the fastest growing fields in alternative medicine. It is a holistic treatment of caring for the body with pleasant// smelling botanical oils. It is widely used at home, clinics and hospitals for a variety of applications such as pain relief for women in labor pain, relieving pain caused by the side effects of the chemotherapy und...

New Study Shows Efficacy of AROMASIN on Early Breast Cancer

New data from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-33 study, presented today at the San Antonio Breast Cancer Symposium, showed that// postmenopausal women with hormone receptor-positive breast cancer who received Aromasin after five years of tamoxifen were 56% less likely to have a relapse of breast cancer than those who received placebo (P=0.004). “Aroma...

Early Switch to an Aromatase Inhibitor Increases Survival

For breast cancer patients taking tamoxifen, switching to an aromatase inhibitor within three years significantly improves survival rates//, according to a new study. The study reveals that the clear survival benefit was also achieved without an increased risk of death from other causes – a significant risk associated with tamoxifen. Hormone modulating therapies have made a significa...